BIM
WST icon

Breakwater Investment Management’s West Pharmaceutical WST Stock Holding History

Breakwater Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$551 – 568
2025
Q4 		$551 Hold
2
– – ﹤0.01% 386
2025
Q3 		$525 Buy
+2
New +$486 ﹤0.01% 406

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Breakwater Investment Management's WST Position: Q1 2026 in Review

Breakwater Investment Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 2 shares — an estimated $551 sold.

Breakwater Investment Management first reported a position in WST in Q3 2025 and held it in 2 quarters. The position peaked at $551 in Q4 2025. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Breakwater Investment Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Breakwater Investment Management sold 2 West Pharmaceutical shares in Q1 2026, an estimated $551.
  • Breakwater Investment Management first reported a position in West Pharmaceutical in Q3 2025 and held it in 2 quarters.
  • Breakwater Investment Management's West Pharmaceutical position peaked at $551 in Q4 2025.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Breakwater Investment Management's 13F filing for Q1 2026, filed 15 May 2026.